SNTI (Senti Biosciences Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Senti Biosciences Holdings, Inc. Common Stock (SNTI) is a publicly traded Healthcare sector company. As of May 21, 2026, SNTI trades at $0.95 with a market cap of $29.28M and a P/E ratio of -0.35. SNTI moved +7.91% today. Year to date, SNTI is -13.27%; over the trailing twelve months it is -69.38%. Its 52-week range spans $0.77 to $16.94. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces SNTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SNTI stock?

Hedge funds tracked by Rallies that own SNTI include Citadel Advisors, Two Sigma, and Renaissance Technologies. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Senti Biosciences Holdings, Inc. Common Stock.

SNTI Key Metrics

Key financial metrics for SNTI
MetricValue
Price$0.95
Market Cap$29.28M
P/E Ratio-0.35
EPS$-2.73
Dividend Yield0.00%
52-Week High$16.94
52-Week Low$0.77
Volume81
Avg Volume0
Revenue (TTM)$22.00K
Net Income$-61.44M
Gross Margin0.00%

Top Hedge Funds Holding SNTI

  • Citadel Advisors holds 79.00K shares of SNTI, changed +80.78% as of Mar 31, 2024.
  • Two Sigma holds 69.75K shares of SNTI, changed -25.50% as of Jun 30, 2024.
  • Renaissance Technologies holds 51.60K shares of SNTI, changed +114.09% as of Dec 31, 2024.

Latest SNTI News

Recent SNTI Insider Trades

  • Lu Timothy K sold 545 (~$2.38K) on Feb 6, 2025.
  • Rajangam Kanya sold 182 (~$795.34) on Feb 6, 2025.
  • Lu Timothy K sold 3.92K (~$15.96K) on Feb 4, 2025.

SNTI Analyst Consensus

1 analysts cover SNTI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Common questions about SNTI

Who owns SNTI stock?
Hedge funds tracked by Rallies that own SNTI include Citadel Advisors, Two Sigma, and Renaissance Technologies. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Senti Biosciences Holdings, Inc. Common Stock.
Does Rallies show 13F holders for SNTI?
Yes. Rallies tracks hedge fund and 13F ownership data for SNTI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SNTI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNTI. It does not provide personalized investment advice.
SNTI

SNTI